Clinical Scorecard: Coding: Reimbursement for OCT Angiography
At a Glance
| Category | Detail |
|---|---|
| Condition | Retinal vascular pathology and related ocular and neurological conditions |
| Key Mechanisms | Non-invasive imaging of retinal and choroidal vessels using OCT angiography without dye injection |
| Target Population | Patients with retinal, optic nerve, uveitis, and neurological vascular conditions |
| Care Setting | Ophthalmic diagnostic and clinical care settings |
Key Highlights
- New CPT code 92137 introduced for OCT angiography including interpretation and report.
- OCTA provides high-resolution, dye-free imaging of retinal and choroidal vasculature using movement of red blood cells.
- Medicare payment for CPT 92137 is $57 nationally, with technical and professional components, subject to MPPR.
Guideline-Based Recommendations
Diagnosis
- Use OCTA to diagnose retinal vascular diseases such as diabetic retinopathy, AMD, vascular occlusions, and macular telangiectasia.
- Apply OCTA for optic nerve conditions including glaucoma vascular factors, AION, and optic neuritis.
- Employ OCTA in uveitis for inflammatory vasculitis, birdshot chorioretinopathy, and cystoid macular edema.
- Consider OCTA in neurology for Alzheimer's disease and other dementias.
Management
- Document detailed findings beyond 'abnormal' to support medical necessity.
- Do not report CPT 92137 on the same date as codes 92133 or 92134.
- Obtain appropriate patient financial responsibility forms (ABN, NEHB) when coverage is uncertain.
Monitoring & Follow-up
- Monitor payor policies and Local Coverage Articles for updates on coverage and reimbursement.
- Track claims processing and payment rates to ensure correct reimbursement.
- Educate staff on new code usage and documentation requirements.
Risks
- Potential patient financial liability if payors deny coverage due to newness of code.
- Risk of improper coding if CPT 92137 is billed with conflicting codes on the same day.
- Possible delays or denials in reimbursement due to limited payor guidance.
Patient & Prescribing Data
Patients undergoing retinal, optic nerve, uveitis, or neurological vascular evaluation
OCTA is a safer, faster alternative to dye-based angiography with fewer adverse reactions and provides detailed vascular imaging to guide diagnosis and monitoring.
Clinical Best Practices
- Ensure thorough documentation of OCTA findings with precise descriptions and image storage locations.
- Inform patients about potential noncoverage and obtain appropriate financial responsibility notices prior to testing.
- Separate billing of CPT 92137 from other OCT codes on the same day to comply with CPT guidelines.
- Stay updated on Medicare and commercial payer policies regarding OCTA coverage and reimbursement.
- Educate clinical and billing staff on the new CPT code and related documentation and billing requirements.
References
- Koustenis A Jr et al. Optical coherence tomography angiography overview
- Leitgeb RA. En face optical coherence tomography technology review
- Le PH, Kaur K, Patel BC. Optical Coherence Tomography Angiography - StatPearls
- AAO EyeWiki. Optical coherence tomography angiography
- Rifai OM et al. OCTA in Alzheimer’s disease systematic review
- First Coast Solutions Medicare Administrative Contractor
- Novitas Solutions Medicare Administrative Contractor
- 2025 CPT Professional Edition
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







